Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Retina's blood vessels can predict stroke risk accurately, offering a non-invasive screening approach for primary healthcare ...

Denali Therapeutics Inc. DNLI announced disappointing top-line results from an analysis of Regimen G of the phase II/III ...

Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating ...

RSV infections in children younger than 5 years in primary care are associated with substantial symptomatology, health-care ...

Children with asthma who visited an allergy specialist were 21% less likely to visit the ED or be hospitalized compared with ...

NVS' phase III study on experimental gene therapy candidate Intrathecal onasemnogene abeparvovec (OAV101IT) meets its primary ...

These meetings on Wednesday, Jan. 15, and Thursday, Jan. 16, are to gather public feedback and ensure the transit system ...

Encouraging primary care physicians to screen patients for physical inactivity with a simple questionnaire can help identify ...

Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

The company had $583.3 million in cash as of September 30th of 2024; Enough cash to fund its operations until the end of 2027 ...

In this study of antipsychotic prescribing in a large primary care database representative of the UK, approximately half of the prescriptions for first-generation and second-generation antipsychotics ...